Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 21st October 2020 from 07:00 AM to 07:00 PM (BST).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 16, 2016
Previous Article Next Article

Increasing anti-cancer activity with longer tether lengths of group 9 Cp* complexes

Author affiliations

Abstract

Here in, we report the cytotoxicity of both rhodium and iridium functionalised Cp* analogues of the [Cp*MCl2]2 dimers. The functionalised dimers contain a hydroxy tethered arm of differing carbon length. These show promising IC50 values when tested against HT-29, A2780 and cisplatin-resistant A2780cis human cancer cell lines, with the cytotoxicity improving proportionally with an increase in carbon tether length of the Cp* ring. The most promising results are seen for the 14-carbon Cp* tethered rhodium (2d) and iridium (3b) complexes, which show up to a 24-fold increase in IC50 compared to the unfunctionalised [Cp*MCl2]2 dimer. All complexes were potent inhibitors of purified thioredoxin reductase suggesting that disruption of cellular anti-oxidant function is one potential mechanism of action.

Graphical abstract: Increasing anti-cancer activity with longer tether lengths of group 9 Cp* complexes

Back to tab navigation

Supplementary files

Article information


Submitted
14 Jan 2016
Accepted
16 Feb 2016
First published
17 Feb 2016

Dalton Trans., 2016,45, 6812-6815
Article type
Communication
Author version available

Increasing anti-cancer activity with longer tether lengths of group 9 Cp* complexes

Stephanie. J. Lucas, R. M. Lord, A. M. Basri, S. J. Allison, R. M. Phillips, A. J. Blacker and P. C. McGowan, Dalton Trans., 2016, 45, 6812
DOI: 10.1039/C6DT00186F

Social activity

Search articles by author

Spotlight

Advertisements